Healixa Inc. Logo

Healixa Inc.

EMOR

(0.0)
Stock Price

0,05 USD

-787.36% ROA

30.57% ROE

-16.1x PER

Market Cap.

57.995.630,00 USD

-64.99% DER

0% Yield

-480.46% NPM

Healixa Inc. Stock Analysis

Healixa Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Healixa Inc. Fundamental Stock Analysis
# Analysis Rating
1 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

2 ROE

Unidentified ROE

3 ROA

Unidentified ROA

4 PBV

Unidentified ROA

5 DER

Unidentified DER

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Graham Number

Unidentified Graham Number

10 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

11 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

Healixa Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Healixa Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Healixa Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Healixa Inc. Revenue
Year Revenue Growth
2011 36.680
2012 64.235 42.9%
2017 9.645 -565.99%
2018 6.724 -43.44%
2019 117.932 94.3%
2020 59.447 -98.38%
2021 0 0%
2022 8.822 100%
2023 598.885 98.53%
2024 511.640 -17.05%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Healixa Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2011 0
2012 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Healixa Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2011 0
2012 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Healixa Inc. EBITDA
Year EBITDA Growth
2011 -91.000
2012 -172.980 47.39%
2017 -48.080 -259.78%
2018 -298.400 83.89%
2019 -997.190 70.08%
2020 -2.988.250 66.63%
2021 -2.596.200 -15.1%
2022 -521.980 -397.38%
2023 -6.320.350 91.74%
2024 -680.480 -828.81%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Healixa Inc. Gross Profit
Year Gross Profit Growth
2011 -2.143
2012 -6.015 64.37%
2017 8.409 171.53%
2018 724 -1061.46%
2019 -54.924 101.32%
2020 -49.524 -10.9%
2021 -23.035 -114.99%
2022 -24.286 5.15%
2023 210.810 111.52%
2024 34.624 -508.86%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Healixa Inc. Net Profit
Year Net Profit Growth
2011 -330.667
2012 -419.502 21.18%
2017 -49.612 -745.57%
2018 -336.726 85.27%
2019 -1.106.959 69.58%
2020 -15.057.567 92.65%
2021 -2.842.986 -429.64%
2022 -645.424 -340.48%
2023 -6.730.220 90.41%
2024 -846.648 -694.93%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Healixa Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2011 0
2012 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Healixa Inc. Free Cashflow
Year Free Cashflow Growth
2011 -164.104
2012 -531.402 69.12%
2017 -7.947 -6586.83%
2018 -15.633 49.17%
2019 -1.238.984 98.74%
2020 -1.657.283 25.24%
2021 -1.808.984 8.39%
2022 -2.139.325 15.44%
2023 -879.366 -143.28%
2024 -82.902 -960.73%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Healixa Inc. Operating Cashflow
Year Operating Cashflow Growth
2011 -163.857
2012 -359.784 54.46%
2017 -7.947 -4427.29%
2018 -15.633 49.17%
2019 -965.123 98.38%
2020 -1.635.512 40.99%
2021 -1.693.984 3.45%
2022 -2.139.325 20.82%
2023 -879.366 -143.28%
2024 -82.902 -960.73%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Healixa Inc. Capital Expenditure
Year Capital Expenditure Growth
2011 247
2012 171.618 99.86%
2017 0 0%
2018 0 0%
2019 273.861 100%
2020 21.771 -1157.92%
2021 115.000 81.07%
2022 0 0%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Healixa Inc. Equity
Year Equity Growth
2011 83.740
2012 129.975 35.57%
2017 69.927 -85.87%
2018 102.421 31.73%
2019 59.107.824 99.83%
2020 67.187.101 12.03%
2021 -5.917.398 1235.42%
2022 -10.886.930 45.65%
2023 -9.949.232 -9.42%
2024 -10.073.326 1.23%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Healixa Inc. Assets
Year Assets Growth
2011 197.896
2012 587.793 66.33%
2017 94.917 -519.27%
2018 102.421 7.33%
2019 60.734.278 99.83%
2020 68.792.814 11.71%
2021 384.759 -17779.46%
2022 562.671 31.62%
2023 624.971 9.97%
2024 538.195 -16.12%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Healixa Inc. Liabilities
Year Liabilities Growth
2011 114.156
2012 457.818 75.07%
2017 24.990 -1732%
2018 0 0%
2019 1.626.454 100%
2020 1.605.713 -1.29%
2021 6.302.157 74.52%
2022 11.449.601 44.96%
2023 10.574.203 -8.28%
2024 10.611.521 0.35%

Healixa Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0
Price to Earning Ratio
-16.1x
Price To Sales Ratio
83.63x
POCF Ratio
-102.69
PFCF Ratio
-110.99
Price to Book Ratio
-5.33
EV to Sales
92.97
EV Over EBITDA
-21.62
EV to Operating CashFlow
-123.39
EV to FreeCashFlow
-123.39
Earnings Yield
-0.06
FreeCashFlow Yield
-0.01
Market Cap
0,06 Bil.
Enterprise Value
0,06 Bil.
Graham Number
0.04
Graham NetNet
-0.01

Income Statement Metrics

Net Income per Share
-0
Income Quality
0.16
ROE
0.31
Return On Assets
-6.19
Return On Capital Employed
0.3
Net Income per EBT
1
EBT Per Ebit
1.11
Ebit per Revenue
-4.35
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.45
Operating Profit Margin
-4.35
Pretax Profit Margin
-4.8
Net Profit Margin
-4.8

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.86
Return on Tangible Assets
-7.87
Days Sales Outstanding
118.34
Days Payables Outstanding
611.4
Days of Inventory on Hand
0
Receivables Turnover
3.08
Payables Turnover
0.6
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,01
Tangible Book Value per Share
-0.01
Shareholders Equity per Share
-0.01
Interest Debt per Share
0.01
Debt to Equity
-0.65
Debt to Assets
12.16
Net Debt to EBITDA
-2.17
Current Ratio
0.04
Tangible Asset Value
-0,01 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
-10111006
Working Capital
-0,01 Bil.
Intangibles to Total Assets
0.21
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.11

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Healixa Inc. Dividends
Year Dividends Growth

Healixa Inc. Profile

About Healixa Inc.

Healixa Inc. operates as a technology company with assets in both healthtech and fintech. It offers tech solutions to enterprise partner channels across a range of industries, including employer benefits, travel, pharma, logistics, and other. Healixa Inc. also operates digital pharmacy marketplace. The company was formerly known as Emerald Organic Products Inc. and changed its name to Healixa Inc. in April 2021. The company was founded in 1977 and is based in Holbrook, New York.

CEO
Mr. Ian Parker
Employee
0
Address
331 Dante Court
Holbrook, 11741

Healixa Inc. Executives & BODs

Healixa Inc. Executives & BODs
# Name Age
1 Senator Richard Lee Alloway II, Esq.
Senior Vice President of Public Affairs
70
2 Mr. Evan DeMarco
C.M.O
70
3 Mr. Ian Parker
Chairman & Chief Executive Officer
70
4 Bret Hedges
SVice President of Strategic Partnerships
70
5 Ms. Diane M. Koontz
President of Healixa Health Care
70

Healixa Inc. Competitors

CareCloud, Inc. Logo
CareCloud, Inc.

CCLD

(1.2)
Vitalhub Corp. Logo
Vitalhub Corp.

VHIBF

(2.8)
Cue Health Inc. Logo
Cue Health Inc.

HLTH

(1.2)
Sharecare, Inc. Logo
Sharecare, Inc.

SHCRW

(1.2)
CareMax, Inc. Logo
CareMax, Inc.

CMAX

(1.5)
Augmedix, Inc. Logo
Augmedix, Inc.

AUGX

(0.5)
Premier, Inc. Logo
Premier, Inc.

PINC

(2.8)
HealthStream, Inc. Logo
HealthStream, Inc.

HSTM

(2.2)
Aclarion, Inc. Logo
Aclarion, Inc.

ACON

(0.5)
LifeMD, Inc. Logo
LifeMD, Inc.

LFMDP

(2.0)
Forian Inc. Logo
Forian Inc.

FORA

(0.5)
MSP Recovery, Inc. Logo
MSP Recovery, Inc.

LIFW

(0.2)